Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA bans red dye 3
Now that the FDA has banned red dye No. 3, what about more common food dyes?
Following the ban of red dye No. 3 in the United States, experts weigh in on the potential health risks of red dye No. 40, yellow No. 5 and others.
FDA ban on dye Red 3 sparks calls for more food safety reform: "It's about time"
Red 3, often used in cakes, candies and drinks to achieve a bright cherry-red color, has long been criticized for its health risks.
FDA bans red dye No. 3 from foods
U.S. regulators are banning the dye called Red 3 from the food supply. The move comes nearly 35 years after the dye was barred from cosmetics such as lipsticks because of potential cancer risk.
FDA approves 20 ZYN Nicotine pouches
FDA officially authorizes Zyn nicotine pouches for sale following health review
The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an "extensive scientific review" about their safety.
FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers
Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit cigarettes.
FDA authorizes Zyn nicotine pouches, cites lower risk than cigarettes
The FDA authorized the marketing of 20 Zyn products on Thursday, marking the first allowance for the fast-growing nicotine pouches.
Amgen wins FDA nod for Lumakras
US FDA approves Amgen's colorectal cancer therapy
The U.S. Food and Drug Administration approved Amgen's combination therapy on Thursday to treat colorectal cancer in patients with a specific gene mutation. Amgen's Lumakras in combination with Vectibix was approved to treat adult patients whose cancer has spread to other parts of the body despite receiving chemotherapy,
Amgen announces FDA approval of Lumakras in combination with Vectibix
Amgen (AMGN) announced that the U.S. FDA has approved Lumakras in combination with Vectibix for the treatment of adult patients with KRAS
Amgen wins FDA nod for Lumakras as a drug combo for colorectal cancer
The U.S. Food and Drug Administration (FDA) has approved Amgen’s (NASDAQ:AMGN) KRASG12C inhibitor Lumakras as part of a combination regimen for adults with metastatic colorectal cancer (mCRC) whose tumors harbor an abnormal gene known as KRAS G12C.
7h
on MSN
Outgoing FDA chief flags online weight loss drug dangers
By Ahmed Aboulenein WASHINGTON (Reuters) -Current laws and regulations are not enough to protect Americans from the risks of ...
2d
FDA moves to cut nicotine from cigarettes, in plan first floated under Trump
Zeller credited Gottlieb for advocating for the nicotine regulation within the Trump White House, after the Obama ...
7h
Califf concludes 2nd FDA stint
FDA Commissioner Robert Califf is closing the book on his second stint leading the agency that regulates products accounting ...
5h
US FDA approves AstraZeneca's drug for breast cancer
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
1d
Yogurt Recall Update As FDA Sets Risk Level Over Plastic Contamination
Greek yogurt has been recalled because it may contain foreign objects, given the FDA's second-most severe risk level.
2d
FDA proposes limiting nicotine levels in cigarettes, other tobacco products
The Food and Drug Administration proposed a new rule on Wednesday limiting nicotine levels in cigarettes and certain other ...
The American Journal of Managed Care
7h
FDA Grants 2 Traditional Approvals for Acalabrutinib
The Bruton tyrosine kinase inhibitor was approved in combination with bendamustine and rituximab in previously untreated ...
6h
on MSN
FDA's Suggested Change to Food Packaging Raises Concerns Among Experts
Newsweek spoke to experts about the FDA's suggestion to place nutrition information on the front of packaged foods.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Food and Drug Administration
Trump
red dye
Zyn
Erythrosine
Feedback